We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$274M
AUM Growth
-$226M
Cap. Flow
-$218M
Cap. Flow %
-79.62%
Top 10 Hldgs %
48.16%
Holding
77
New
14
Increased
9
Reduced
38
Closed
15

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$5.15M
2
CPAY icon
Corpay
CPAY
+$4.93M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.51M
4
VIPS icon
Vipshop
VIPS
+$3.73M
5
PHM icon
Pultegroup
PHM
+$3.22M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$18.8M
2
WBA
Walgreens Boots Alliance
WBA
+$17.8M
3
MCK icon
McKesson
MCK
+$15.3M
4
BKNG icon
Booking.com
BKNG
+$14.9M
5
RAD
Rite Aid Corporation
RAD
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 24.49%
2 Communication Services 22.64%
3 Materials 11.25%
4 Technology 10.65%
5 Energy 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
51
Cardinal Health
CAH
$55.8B
$258K 0.09%
+3,443
New +$251K
MOH icon
52
Molina Healthcare
MOH
$10.1B
$256K 0.09%
6,061
-9,973
-62% -$441K
ARAV
53
DELISTED
Aravive, Inc. Common Stock
ARAV
$237K 0.09%
2,083
-284
-12% -$37.6K
MRK icon
54
Merck
MRK
$317B
$203K 0.07%
+3,582
New +$201K
RVNC
55
DELISTED
Revance Therapeutics, Inc.
RVNC
$172K 0.06%
8,906
-13
-0.1% -$339
CNC icon
56
Centene
CNC
$32.5B
$143K 0.05%
+6,928
New +$134K
EIGR
57
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$140K 0.05%
30
-4
-12% -$21.1K
AGIO icon
58
Agios Pharmaceuticals
AGIO
$1.9B
$126K 0.05%
+2,052
New +$88.4K
BMY icon
59
PUT
Bristol-Myers Squibb
BMY
$131B
$29K 0.01%
+49,300
New +$2.46M
WYNN icon
60
CALL
Wynn Resorts
WYNN
$10.6B
$27K 0.01%
+87,300
New +$17.2M
MRK icon
61
CALL
Merck
MRK
$317B
$20K 0.01%
+21,170
New +$1.19M
AAP icon
62
Advance Auto Parts
AAP
$3.46B
– –
-80,980
Closed -$10.9M
AXP icon
63
American Express
AXP
$230B
– –
-90,514
Closed -$8.59M
BKNG icon
64
Booking.com
BKNG
$161B
– –
-308,725
Closed -$14.9M
NOW icon
65
ServiceNow
NOW
$129B
– –
-441,860
Closed -$5.48M
PARA
66
DELISTED
Paramount Global Class B
PARA
– –
-86,579
Closed -$5.38M
SBUX icon
67
Starbucks
SBUX
$121B
– –
-236,188
Closed -$9.14M
TEX icon
68
Terex
TEX
$7.71B
– –
-113,751
Closed -$4.67M
TMO icon
69
Thermo Fisher Scientific
TMO
$216B
– –
-6,765
Closed -$798K
VNET
70
VNET Group
VNET
$2.08B
– –
-90,297
Closed -$2.71M
VTRS icon
71
Viatris
VTRS
$19.3B
– –
-5,626
Closed -$290K
WBA
72
DELISTED
Walgreens Boots Alliance
WBA
– –
-240,533
Closed -$17.8M
IPXL
73
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-20,295
Closed -$609K
AEGR
74
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-12,637
Closed -$406K
RCPT
75
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-2,717
Closed -$116K
1 2
3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2014 Portfolio in Review

As of Q3 2014, Partner Investment Management held 77 positions worth $274M, down 45% from $499M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Partner Investment Management withdrew a net $218M in Q3 2014, closing 15 positions and reducing 38 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 32% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Partner Investment Management opened a new position in Corpay worth $5.09M.

  • Partner Investment Management's largest Q3 2014 buy was Corpay: 35,823 shares worth $5.09M.
  • Partner Investment Management added most to Baidu in Q3 2014, an estimated $5.15M increase.
  • Partner Investment Management's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $18.8M.
  • Partner Investment Management fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $17.8M.
  • Partner Investment Management's ten largest holdings make up 48% of its $274M portfolio in Q3 2014.
  • Partner Investment Management opened 14 new positions and closed 15 in Q3 2014.
  • Partner Investment Management's portfolio value fell 45% quarter-over-quarter to $274M.

Based on Partner Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.